Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Impax Laboratories Inc    IPXL   US45256B1017

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Impax Laboratories Inc : Impax Laboratories to Present at the UBS Global Healthcare Conference

05/20/2013 | 08:35am US/Eastern

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the UBS Global Healthcare Conference on Wednesday, May 22, at 9:00 a.m. Eastern Standard Time. The conference will be held at the Sheraton New York Hotel.

Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company's web site at www.impaxlabs.com. This presentation will be archived on the Company's web site for 30 days.

About Impax Laboratories, Inc.

Impax Laboratories, Inc. (Impax) is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax develops marketing partnerships to fully leverage its technology platform and pursues partnership opportunities that offer alternative dosage form technologies, such as injectables, nasal sprays, inhalers, patches, creams and ointments. For more information, please visit the Company's Web site at: www.impaxlabs.com.

Impax Laboratories, Inc.
Mark Donohue, 215-558-4526
Investor Relations and Corporate Communications
www.impaxlabs.com


© Business Wire 2013
Latest news on IMPAX LABORATORIES INC
2d ago IMPAX LABORATORIES : Change in Directors or Principal Officers (form 8-K)
3d ago IMPAX LABORATORIES : Announces Departure of Carole Ben-Maimon, M.D., President o..
4d ago IMPAX LABORATORIES : Announces Departure of Carole Ben-Maimon, M.D., President o..
10/15 IMPAX LABORATORIES : Lieff Cabraser Reminds Impax Laboratories, Inc. Investors o..
10/15 IMPAX LABORATORIES : to Announce Results for Third Quarter 2014 on November 4
10/15 IMPAX LABORATORIES : To Acquire Tower Holdings, Inc. And Lineage Therapeutics In..
10/15 IMPAX LABORATORIES : INVESTOR ALERT: Glancy Binkow & Goldberg LLP Announces Upda..
10/10 IMPAX LABORATORIES : Entry into a Material Definitive Agreement, Creation of a D..
10/10 IMPAX ASSET MANAGEMENT : Says Operating Earnings To Beat Market Hopes
10/09 IMPAX LABORATORIES : Labs to spend $700M on Tower Holdings
Advertisement
Chart
Duration : Period :
Impax Laboratories Inc Technical Analysis Chart | IPXL | US45256B1017 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF